In our cohort of patients with community acquired critical illness we could not demonstrate any significant associations between hepcidin levels at admission and stage 2–3 acute kidney injury, renal replacement therapy, or peak creatinine levels in neither sepsis nor non-sepsis patients. This evidence concerns the gene HAMP and acute kidney injury.